Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on August 19, 2014. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Laboratory Biologic - Human TC Serum

Closed
2014-76322Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

21 days ago

DEADLINE

in 19 days

General Info

Agency

N/A

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Deliver to CDC Distribution Center (Warehouse), 3719 North Peachtree Road, Chamblee, GA, 30341-2221, USA

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Lenore MickleContract Specialist
Stephanie CruzContrac Officer

Full Description

Show more
The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Solomon Park Research Laboratories, Inc., for the following: (21,600) Single donor units of commutable frozen human serum derived from units of whole blood from Solomon Park Laboratories. The single donor units will be made from (5) serum pools totaling approximately 8,000 vials of serum. 1. 3600 units of C37-A-474 Normal TC human serum pool: Normal TC: C37-A-474 human TC serum pool. Quantity: 1000 1.3 ml per vial for LSP and Quantity: 1000 vials at 2.3 ml per vial for CRMLN TCh 150 mg/dL HDLC >or= to 60 mg/dL 2. 3600 units of C37-A-485 Low HDLC human serum pool: Low HDLC: C37-A-485 human HDLC serum pool. Quantity: 1000 1.3 ml per vial for LSP and Quantity: 1000 vials at 2.3 ml per vial for CRMLN. HDLC 32+/-2 mg/dL 3. 3600 units of C37-A-476 High TC human serum pool: C37-A-476 human TC serum pool.Quantity: 1000 1.3 ml per vial for LSP and Quantity: 1000 vials at 2.3 ml per vial for CRMLN. TCh > or = 240 mg/dL 4. 5400 units of C37-A-L67 human LDLC serum pool: C37-A-L67 human LDLC serum pool, 5.4 ml per vial, ~70 - 2 mg/dL Quantity: 1000 vials 5. 5400 units of C37-A-L69 human LDLC serum pool: C37-A-L69 human LDLC serum pool, 5.4 ml per vial, ~100 - 2 mg/dL Quantity: 1000 vials 6. Frozen large shippers with dry ice 7. Overnight shipping This supply of units of serum pool with supplies is needed for the assessment of lipids, to calibrate assays used in routine patient care and to assure continuity of the CDC/NCEH/DLS/CCB/Protein Biomarker Laboratory/Lipid Standardization Program biomonitoring and chronic disease projects. Solomon Park Research Laboratories is the only known vendor who can provide the products with consistent quality, efficiency and reliability collecting units according to CLSI C37 protocols to insure compliance Clinical and Laboratory Standards Institute Guidelines and Standardization Programs, as requested to meeting the program needs. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at lmickle@cdc.gov by 2:30PM eastern time on August 26, 2014.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS